Duopa FDA Approval History
FDA Approved: Yes (First approved January 12, 2015)
Brand name: Duopa
Generic name: carbidopa and levodopa
Dosage form: Enteral Suspension
Company: AbbVie Inc.
Treatment for: Parkinson's Disease
Duopa (carbidopa and levodopa) is an aromatic amino acid decarboxylation inhibitor and aromatic amino acid combination formulated as an enteral suspension for the treatment of motor fluctuations in patients with advanced Parkinson’s disease.
Development timeline for Duopa
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
